PRODUCT DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN SHIRE LLC AND DURAMED PHARMACEUTICALS, INC. DATED AS OF AUGUST 14, 2006Supply Agreement • November 9th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
This PRODUCT DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is dated as of August 14, 2006 by and among SHIRE LLC, a Kentucky limited liability company having a principal place of business at 9200 Brookfield Court, Florence, Kentucky 41042 (together with its Affiliates, “Shire”), SHIRE plc, a British public limited company having a principal place of business at Hampshire International Business Park, Chineham, Basingstoke, England RG24 8EP, solely for purposes of the provisions of Section 15.10 of this Agreement, and DURAMED PHARMACEUTICALS, INC., a Delaware corporation having a place of business at 400 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“Duramed”). Shire and Duramed are sometimes referred to herein individually as a “Party” and together as the “Parties”.
PRODUCT ACQUISITION AND LICENSE AGREEMENT (Adderall®) BY AND AMONG SHIRE LLC, SHIRE PLC AND DURAMED PHARMACEUTICALS, INC. DATED AS OF AUGUST 14, 2006Supply Agreement • November 9th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS PRODUCT ACQUISITION AND LICENSE AGREEMENT is dated as of August 14, 2006, by and among Shire LLC, a Kentucky limited liability company (together with its Affiliates, “Shire”), Shire plc a British public limited company, and Duramed Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware (“Duramed”). Shire and Duramed are sometimes referred to herein individually as a “Party” and together as the “Parties”.
SETTLEMENT AGREEMENT Dated as of August 14, 2006 SHIRE LABORATORIES INC. and BARR LABORATORIES, INC.Settlement Agreement • November 9th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SETTLEMENT AGREEMENT, (this “Settlement Agreement”) dated as of this 14th day of August, 2006, is hereby entered into by and between Shire Laboratories Inc., a Delaware corporation with offices located at 725 Chesterbrook Boulevard, Wayne, PA 19087 (“Shire”), and Barr Laboratories, Inc., a Delaware corporation with offices located at 400 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“Barr”). Each of Shire and Barr is sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”
